COMS

GTC is proud to present our 2nd Annual Ubiquitin Research and Drug Development Conference! This meeting, taking place on February 27-28, 2012 at the Red Rock Resort & Spa in Las Vegas, NV, will bring together leaders from biotech and pharmaceutical companies, academia, and government, to provide you with a solid primer for a better understanding of the complex activities of ubiquitin and ubiquitin-like proteins and some solutions to the challenges associated with ubiquitin drug development.

The 21st century presents global challenges in the environment, resources, energy, health, and sustainability. The Institute of Biological Engineering supports the community of scientists and engineers that are addressing these problems through biological systems analysis and design. We do this through enhancing and promoting biological engineering in the broadest manner through research, education, and professional development.

The emerging discipline of biological engineering lies at the interfaces of biological sciences, engineering sciences, mathematics and computational sciences. It applies biological systems to enhance of the quality and diversity of life.

The 6th Biomarker Development Conference offers attendees insight into the latest developments from the leading players will offering a unique networking opportunity.

Offering a unique opportunity, the Biomarker Partnering and Deal-Making Conference assembles leading players to discuss what needs to be accomplished to lead the industry into its next phase. The business of biomarkers has reached an exciting and critical stage and intelligence and strategic relationship building is more important than ever. Attendees will be able to set the stage for both at this leading event.

Recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, stem cell reprogramming, and regulatory policies regarding stem cell research will be addressed. In addition, focuses on the business opportunities, challenges and potential strategies for overcoming these challenges will be addressed. What categories of companies are currently commercially viable? How are they being funded? What kind of strategic relationships are available within the industry?

The theme of this conference will be the use of novel experimental and computational approaches to study signalling networks, and how network models can be applied to the study and targeting of complex diseases such as cancer, diabetes and neurological disorders.

The collegial atmosphere of this GRC with ample time for discussion during the oral sessions as well as opportunities for discussions during informal gatherings in the afternoons and evenings provides an avenue for scientists/engineers from diverse disciplines to brainstorm and promote new cross-disciplinary collaborations in the various research areas represented.

In addition, the Gordon Research Seminar (GRS) will convene immediately preceding the GRC (15 - 16 June 2012). Organized and conducted by graduate students and postdocs, the GRS will provide an opportunity for junior scientists to present their work in a formal and oral or poster format in front of their peers. These students will participate in the subsequent Bioanalytical Sensors GRC providing a unique opportunity to promote interactions between future researchers and established ones.